Invention Grant
US08716527B2 2-substituted-p-quinone derivatives for treatment of oxidative stress diseases
有权
用于治疗氧化应激疾病的2-取代的对醌衍生物
- Patent Title: 2-substituted-p-quinone derivatives for treatment of oxidative stress diseases
- Patent Title (中): 用于治疗氧化应激疾病的2-取代的对醌衍生物
-
Application No.: US12919007Application Date: 2009-03-04
-
Publication No.: US08716527B2Publication Date: 2014-05-06
- Inventor: Andrew W. Hinman , Kieron E. Wesson , Orion D. Jankowski , Paul Mollard , William D. Shrader , Christopher R. Cornell
- Applicant: Andrew W. Hinman , Kieron E. Wesson , Orion D. Jankowski , Paul Mollard , William D. Shrader , Christopher R. Cornell
- Applicant Address: US CA Mountain View
- Assignee: Edison Pharmaceuticals, Inc.
- Current Assignee: Edison Pharmaceuticals, Inc.
- Current Assignee Address: US CA Mountain View
- Agency: Morrison & Foerster LLP
- International Application: PCT/US2009/036051 WO 20090304
- International Announcement: WO2009/111576 WO 20090911
- Main IPC: C07C233/05
- IPC: C07C233/05 ; A61K31/65 ; C07D209/04 ; C07D211/00 ; A61K31/445 ; A61K31/40
Abstract:
Methods of treating or suppressing oxidative stress diseases including mitochondrial diseases, impaired energy processing disorders, neurodegenerative diseases and diseases of aging are disclosed, as well as compounds useful in the methods of the invention, such as 2- substituted-p-quinone derivatives as disclosed herein.
Public/Granted literature
- US20110124679A1 2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES Public/Granted day:2011-05-26
Information query
